Literature DB >> 23157845

Possible induction of acute disseminated encephalomyelitis (ADEM)-like demyelinating illness by intrathecal mesenchymal stem cell injection.

Nirmeen A Kishk1, Noha T Abokrysha, Hala Gabr.   

Abstract

We report a 27-year-old woman with an episode of encephalitis and optic neuritis, followed by autologous bone marrow mesenchymal stem cell transplants and possible induction of acute disseminated encephalomyelitis-like demyelinating illness.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2012        PMID： 23157845     DOI： 10.1016/j.jocn.2012.04.013

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN： 0967-5868            Impact factor:   1.961


  9 in total

Review 1.  Mesenchymal stem cell transplantation in multiple sclerosis.

Authors:  Jeffrey A Cohen
Journal:  J Neurol Sci       Date:  2013-01-04       Impact factor: 3.181

Review 2.  Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions.

Authors:  Gerhard Bauer; Magdi Elsallab; Mohamed Abou-El-Enein
Journal:  Stem Cells Transl Med       Date:  2018-07-31       Impact factor: 6.940

Review 3.  Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.

Authors:  Justin D Glenn; Katharine A Whartenby
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

Review 4.  Cell Therapy for Multiple Sclerosis.

Authors:  Pamela Sarkar; Claire M Rice; Neil J Scolding
Journal:  CNS Drugs       Date:  2017-06       Impact factor: 6.497

5.  Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia.

Authors:  Alison K McLean; Cameron Stewart; Ian Kerridge
Journal:  Stem Cell Res Ther       Date:  2015-02-09       Impact factor: 6.832

6.  Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis-A Phase I Study.

Authors:  Ellen Iacobaeus; Nadir Kadri; Katia Lefsihane; Erik Boberg; Caroline Gavin; Anton Törnqvist Andrén; Anders Lilja; Lou Brundin; Katarina Le Blanc
Journal:  J Clin Med       Date:  2019-12-02       Impact factor: 4.241

Review 7.  Stem Cell Therapy in Neuroimmunological Diseases and Its Potential Neuroimmunological Complications.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Lea Grote-Levi; Nora Möhn; Kurt-Wolfram Sühs; Britta Eiz-Vesper; Britta Maecker-Kolhoff; Corinna Trebst; Thomas Skripuletz; Martin W Hümmert
Journal:  Cells       Date:  2022-07-11       Impact factor: 7.666

8.  Safety and tracking of intrathecal allogeneic mesenchymal stem cell transplantation in healthy and diseased horses.

Authors:  Danielle Jaqueta Barberini; Monica Aleman; Fabio Aristizabal; Mathieu Spriet; Kaitlin C Clark; Naomi J Walker; Larry D Galuppo; Rogério Martins Amorim; Kevin D Woolard; Dori L Borjesson
Journal:  Stem Cell Res Ther       Date:  2018-04-10       Impact factor: 6.832

Review 9.  Cell-based therapeutic strategies for multiple sclerosis.

Authors:  Neil J Scolding; Marcelo Pasquini; Stephen C Reingold; Jeffrey A Cohen
Journal:  Brain       Date:  2017-11-01       Impact factor: 13.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.